Companies Cryptocurrencies
Generation Bio Co
Generation Bio Co
Exchange: NasdaqGS
IPO Date: 12/06/2020
CEO: Dr. Cameron Geoffrey McDonough
Biotechnology Healthcare 🔗
  • GBIO
  • 6.93
  • 395619840
    market cap
  • -0.14000034
If you bought

shares of Generation Bio Co (GBIO) on
You would have made
Old Price $12 Current Price $12

Generation Bio Co. is a genetic medicines company. The Company is developing a class of gene therapy utilizing its non-viral gene therapy platform to provide durable, redosable treatments for patients living with rare and prevalent diseases. The Company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The Company is developing gene therapies to provide targeted delivery of genetic payloads that include multiple genes to a range of tissues of diseases. The Company is also engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The Company is a preclinical stage company and have not identified a product candidate.

Address: 301 BINNEY STREET Cambridge MASSACHUSETTS 02142

Stay updated.